REVIEWS |
|
M.V. Leonova
Clinically significant drug interactions with warfarin: bleeding risk
|
8-14 |
|
D.I. Trukhan
A comorbid patient at a therapeutic reception during the COVID-19 pandemic. Current aspects of the rehabilitation period
|
15-24 |
|
A.I. Listratov, T.M. Ostroumova, A.I. Kochetkov, O.D. Ostroumova, D.A. Sychev
Controversial and unresolved aspects of drug-induced hemorrhagic stroke: focus on selective serotonin reuptake inhibitors, non-steroidal anti-inflammatory drugs and statins
|
26-36 |
|
V.V. Petrova, I.A. Prudnikov, A.A. Petrov, D.A. Sapov
Problems of circadian rhythm control in athletes using somnological and digital technologies (literature review)
|
37-44 |
|
I.V. Menshikova
Efficacy of the combination of chondroitin sulfate and glucosamine hydrochloride in the treatment of osteoarthritis in multimorbid patients
|
45-48 |
|
N.N. Filimonkova, A.R. Temirbulatova, I.D. Kuznetsov
Modern data on localized scleroderma and methods of its therapy
|
49-52 |
|
V.V. Gorban, E.V. Gorban, V.S. Manto
Features of heart rate variability in middle-aged people with arterial hypertension depending on gender and composite body structure
|
53-58 |
|
|
I.I. Miroshnichenko
Towards the development of new effective antipsychotics
|
59-61 |
ORIGINAL ARTICLES |
|
O.D. Ostroumova, I.Yu. Orlova, A.I. Kochetkov, O.A. Polyakova, A.I. Listratov, N.A. Shatalova, S.V. Batyukina
Structure of prescription of gastroprotective drugs in patients receiving direct oral anticoagulants: results of a multicenter cross-sectional pharmacoepidemiological study
|
62-69 |
|
A.A. Kostromina, Yu.R. Khvostantseva, O.G. Filimonova
Dependence of clinical parameters on the presence of arterial hypertension in patients with osteoarthritis
|
70-73 |
|
B.G. Iskenderov, A.V. Zaitseva, I.N. Mozhzhukhin, M.G. Ivanchukova
Impact of coronary artery stenting on the course of chronic kidney disease in patients with stable angina
|
74-79 |
|
S.V. Malchikova, N.S. Trushnikova, M.V. Kazakovtseva, N.S. Maksimchuk-Kolobova
Drug therapy in elderly patients with myocardial infarction
|
80-86 |
|
L.V. Vasilyeva, E.F. Evstratova, E.Yu. Suslova, E.V. Gostev
The role of chondroprotectors in the correction of pain in patients with osteoarthritis of the joints of the hands with Heberden’s nodes
|
87-90 |
|
G.N. Levitsky, A.S. Levitsky, A.G. Sanadze
Comparative assessment of the efficacy and safety of various pharmacological forms of anticholinergic drugs and botulinum therapy for sialorrhea in patients with amyotrophic lateral sclerosis
|
91-97 |
|
E.A. Koltsova, E.A. Petrova, V.V. Grechenko, L.V. Gankovskaya
Changes in TLR2 and TLR4 gene expression in patients with ischemic stroke
|
98-104 |
|
E.I. Vereshchagin, E.V. Svechnikova, N.O. Artemyeva
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout
|
106-109 |
|
F.A. Bushkov, R.G. Fu, A.K. Romanovskaya
Condition of the spine in patients with consequences of cervical spinal cord injury
|
110-114 |
|
D.Z. Khakimova, L.I. Shevchenko, Kh.Ya. Karimov, Zh.D. Khuzhahmedov
Effect of a new blood substitute rheoambrasol on indicators of endogenous intoxication in nitrite-induced methemoglobinemia
|
115-119 |
|
T.I. Bonkalo, A.V. Romanova, M.B. Salamatov, M.A. Kovaleva
Gender features of the axiological orientation of the personality of medical workers
|
120-126 |
|
|
M.Yu. Maksimova, A.S. Airapetova
Post-stroke speech disorders: clinical benefits of using memantine
|
128-133 |
|
O.A. Mubarakshina, M.N. Somova, G.A. Batishcheva
Nadroparin in the treatment of unstable angina and myocardial infarction: a point of view of a clinical pharmacologist
|
134-141 |
|
D.V. Bestaev, A.A. Konushkaliev, E. Mokhamed Hussein
Methotrexate and early rheumatoid arthritis
|
142-144 |
|
E.V. Filippova, O.V. Kolomiets, M.A. Puolokaynen, E.E. Malygin
Modern approaches to the treatment of patients with alcohol withdrawal syndrome
|
145-150 |
|
A.A. Klimenko, N.A. Demidova, D.Yu. Andriyashkina, A.A. Kondrashov, D.V. Somov, A.V. Novikova
Myofascial pain syndrome in a patient with ankylosing spondylitis: experience with tolperisone
|
151-155 |
|
S.D. Shorokhov, P.S. Zolotoy, D.Ch. Tsvynda, E.L. Tyuleva, O.A. Lemekhova
The use of botulinum toxin A as part of complex treatment and rehabilitation measures in a patient with generalized post-stroke dystonia
|
156-158 |
|
V.S. Nikiforov
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
|
159-163 |
Русский
